Patent 7132264 was granted and assigned to Immunex on November, 2006 by the United States Patent and Trademark Office.
This invention relates to Thypin, a new member of the human serpin polypeptide family, methods of making Thypin polypeptides and using these polypeptides to treat various medical disorders and to methods of screening for compounds that agonize or antagonize Thypin polypeptide activities.